Perrigo | PRGO - Current Assets


Perrigo reported $2.88B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Abbott USD 26B 1.16B Dec/2025
Bayer EUR 32.88B 873M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Coherus Biosciences USD 460.96M 80.75M Sep/2025
Corcept Therapeutics USD 541.13M 98.02M Sep/2025
Dr.Reddys Laboratories INR 297.55B 18.03B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Nestle CHF 33.43B 1.76B Jun/2025
Pacira USD 562.75M 182.86M Sep/2025
Perrigo USD 2.88B 264.2M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Prestige Brands USD 433.43M 63.98M Dec/2025
Reckitt Benckiser GBP 4.6B 287M Dec/2024
Sanofi EUR 30.95B 3.09B Dec/2025
Supernus Pharmaceuticals USD 593.89M 144.98M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025
Zoetis USD 6.77B 185M Dec/2025